Sensex turns course, rises 100 pts; RIL, HDFC Bank up 1%

11:57 AM

Ashok Leyland wins order to supply 552 buses to Tamil Nadu transport corpn

Ashok Leyland, the country’s leading commercial vehicle manufacturer, said on Thursday it has won an order from the Tamil Nadu government for providing 552 Ultra-Low Entry (ULE) diesel non-AC buses.

Ashok Leyland, the Indian flagship company of the Hinduja Group, said the Tamil Nadu State Transport Corporation (TNSTC) already operates 18,477 of its buses. The new order marks a “groundbreaking collaboration” between Ashok Leyland and TNSTC in the pursuit of ‘Mobility for All’, the state government’s commitment to promote public transportation, said a press statement. Read

11:42 AM

Piramal Enterprises to adjust Rs 3,164 cr exposure to AIF in its financials

In line with Reserve Bank of India (RBI) directives, Piramal Enterprises has decided to adjust Rs 3,164 crore worth of exposure in Alternative Investment Funds (AIFs) in its financial statements through capital funds or provisions. Read

11:29 AM

Nifty, MidCap, SmallCap: Should you buy the dip? Here’s what charts say

The NSE Nifty50 index tanked as much as 2.9 per cent from its new summit at 21,593 hit on Wednesday, to a low of 20,977 this morning. Prior to this, the Nifty had rallied over 14 per cent in the last two months. Hence, some profit-taking following the smart gains seemed warranted. Read

Markets, bulls, bears, stocks, trading, technicals, market technical, technical analysis

11:16 AM

Stock of this wind energy solutions provider has zoomed 108% in 7 weeks

Shares of Inox Wind (IWL) surged 5 per cent to Rs 444.20 on the BSE in Thursday’s intra-day trade, extending its past one and half month rally amid hopes of improvement in its operating performance.

In the past seven weeks, the market price of IWL has more than doubled or zoomed 108 per cent from a level of Rs 213.70 on November 2. Read

market, stocks, stock market trading, stock market

10:59 AM

VIEW: Use market dip to buy large caps

At high valuations, the market is vulnerable to sharp corrections and this happened yesterday. Two trends are important: one, the correction in mid and small caps is almost double the correction in large caps;

two, DIIs turned big buyers towards the end of the trading day. The vulnerability of the mid and small caps to correction remains since the valuations are excessive.

Large caps will witness buying on declines. Investors can wait for the market to stabilise and buy high quality large cap stocks on declines.

Views by V K Vijayakumar, Chief Investment Strategist at Geojit Financial Services.

10:46 AM

Fresh Covid scare: India records 358 new cases, active caseload rises to 2,669

India recorded a single-day rise of 358 new Covid-19 infections while the active caseload rose to 2,669, according to Union health ministry data updated on Thursday. The surge in cases comes amid a rise in Covid sub-variant JN.1, which was first detected in Kerala. Read

Covid, Covid in india, india coronavirus case

10:30 AM

INOX India makes bumper debut; lists at 44% premium over issue price

INOX India (INOX), the largest domestic supplier of cryogenic equipment, made a strong stock market debut on Thursday with its shares listing at Rs 949.65 on the NSE, a premium over 44 per cent over the issue price of Rs 660. Read

10:15 AM

Indian Bank extends slide to 2nd day; slips 8% after listing of QIP shares

Shares of Indian Bank slipped 8 per cent to Rs 393.55 on the BSE in Thursday’s intra-day trade after 101.5 million equity shares of the company, allotted to qualified institutional buyers (QIBs), got listed on the stock exchanges today. Read

10:03 AM

ALERT: Inox India lists at 41% premium over issue price on BSE

9:43 AM

Praveg up 1%; board to meet Dec 26 to consider fundraise

It has received a govt work order for developing and managing at least 50 tents at Agatti Island, UT of Lakshwadeep. Its board will also meet on Dec 26 to consider fund raise.

9:40 AM

Astrazeneca edges 2% up; to launch breast cancer drug Enhertu in Jan

It will launch Enhertu in January 2024 in India. Trastuzumab deruxtecan (Enhertu) is indicated for the treatment of adult patients with unresectable or metastatic HER2-positive breast cancer.

9:37 AM

Cochin Shipyard rises 2% on contract win worth Rs 488 crore

It has also signed a deal with the defence minstry for a contract of Rs 488.25 crore.

9:36 AM

Mazagon Dock gains 3% on bagging Rs 1,615 crore contract from defence ministry

The company has won an order worth Rs 1615 crore from the defence ministry to supply six vessels to the Indian Coast Guards (ICG).

9:34 AM

Ultratech holds slim losses; to acquire 26% stake in Clean Max

The company has entered into an agreement to acquire 26 per cent stake in Clean Max Terra.

9:33 AM

Allcargo Logistics up 2%; sets Jan 2 as record date for 3:1 bonus issue

It has fixed January 2, 2024 as the record date for its bonus share issue of 3:1.

9:30 AM

Zee Ent jumps 4% as company begins talks with Sony for extension of merger deadline

Sony Pictures Networks has agreed to enter into discussions with the company for a possible extension of the date to complete its merger deal.

9:28 AM

Media index higher amid broad-based slump

9:26 AM

SmallCap index holds in green in weak market

9:25 AM

Axis Bank, Sun Pharma, Cipla top Nifty drags

9:23 AM